Assignee
RINAT NEUROSCIENCE CORP
US·35 granted patents·20 pending applications·501 citations·filing 2003–2023
Top patents by PatentIndex Score
55 records- 0198US8871908B2Antibodies specific for Trop-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2012·Granted Oct 28, 2014·86 cites·26 claims
- 0297US10138303B2Heterodimeric proteins and methods for producing and purifying themRINAT NEUROSCIENCE CORP·Filed 2016·Granted Nov 27, 2018·14 cites·9 claims
- 0397US8007794B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2006·Granted Aug 30, 2011·51 cites·9 claims
- 0497US7425329B2Methods for treating bone cancer pain by administering a nerve growth factor antagonistRINAT NEUROSCIENCE CORP·Filed 2005·Granted Sep 16, 2008·61 cites·17 claims
- 0596US9399074B2Antibodies specific for trop-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2014·Granted Jul 26, 2016·19 cites·19 claims
- 0694US10155037B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2015·Granted Dec 18, 2018·18 cites·45 claims
- 0794US7927594B2Antibodies directed against amyloid-beta peptideRINAT NEUROSCIENCE CORP·Filed 2005·Granted Apr 19, 2011·24 cites·21 claims
- 0894US7763250B2Antibodies directed against amyloid-beta peptide and nucleic acids encoding sameRINAT NEUROSCIENCE CORP·Filed 2006·Granted Jul 27, 2010·23 cites·29 claims
- 0994US7255860B2Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibodyRINAT NEUROSCIENCE CORP·Filed 2003·Granted Aug 14, 2007·61 cites·11 claims
- 1094US7252822B2Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonistRINAT NEUROSCIENCE CORP·Filed 2003·Granted Aug 7, 2007·83 cites·10 claims
- 1189US8034346B2Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the sameRINAT NEUROSCIENCE CORP·Filed 2009·Granted Oct 11, 2011·17 cites·12 claims
- 1286US9175093B2PCSK9 antagonistsRINAT NEUROSCIENCE CORP·Filed 2013·Granted Nov 3, 2015·6 cites·11 claims
- 1385US10660953B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2018·Granted May 26, 2020·2 cites·19 claims
- 1485US9498530B2Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameRINAT NEUROSCIENCE CORP·Filed 2013·Granted Nov 22, 2016·3 cites·11 claims
- 1585US7807165B2Antibodies directed against amyloid-beta peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2005·Granted Oct 5, 2010·5 cites·68 claims
- 1684US10842881B2Engineered polypeptide conjugates using transglutaminaseRINAT NEUROSCIENCE CORP·Filed 2018·Granted Nov 24, 2020·2 cites·6 claims
- 1783US9708398B2Anti-NGF antibodies and methods using sameRINAT NEUROSCIENCE CORP·Filed 2015·Granted Jul 18, 2017·2 cites·13 claims
- 1883US8715673B2Staphylococcus aureus specific antibodies and uses thereofRINAT NEUROSCIENCE CORP·Filed 2012·Granted May 6, 2014·4 cites·15 claims
- 1981US11602525B2Antibody-drug conjugates with high drug loadingRINAT NEUROSCIENCE CORP·Filed 2015·Granted Mar 14, 2023·2 cites·17 claims
- 2081US11390689B2Heterodimeric proteins and methods for producing and purifying themRINAT NEUROSCIENCE CORP·Filed 2018·Granted Jul 19, 2022·1 cites·12 claims
- 2181US9248189B2Anti-glucagon receptor antibodies and pharmaceutical compositions thereofRINAT NEUROSCIENCE CORP·Filed 2014·Granted Feb 2, 2016·5 cites·14 claims
- 2278US10323086B2Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameRINAT NEUROSCIENCE CORP·Filed 2016·Granted Jun 18, 2019·1 cites·16 claims
- 2378US2022332850A1Heterodimeric proteins and methods for producing and purifying themRINAT NEUROSCIENCE CORP·Filed 2022·Application pending·0 cites
- 2476US10195289B2Engineered polypeptide conjugates using transglutaminaseRINAT NEUROSCIENCE CORP·Filed 2014·Granted Feb 5, 2019·3 cites·17 claims
- 2576US10100114B2Antibodies specific for TROP-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2016·Granted Oct 16, 2018·1 cites·9 claims
- 2676US2022249657A1Anti-pd-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2022·Application pending·0 cites
- 2776US2024009319A1Engineered polypeptide conjugates using transglutaminaseRINAT NEUROSCIENCE CORP·Filed 2023·Application pending·0 cites
- 2874US7968690B2Agonist anti-trkC antibodies and methods using sameRINAT NEUROSCIENCE CORP·Filed 2004·Granted Jun 28, 2011·3 cites·16 claims
- 2972US9340610B2Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameRINAT NEUROSCIENCE CORP·Filed 2013·Granted May 17, 2016·1 cites·13 claims
- 3072US2022169713A1Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameRINAT NEUROSCIENCE CORP·Filed 2021·Application pending·0 cites
- 3170US11338035B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2020·Granted May 24, 2022·0 cites·15 claims
- 3270US8637273B2Nucleic acid encoding IL-7 receptor alpha antibodyRINAT NEUROSCIENCE CORP·Filed 2012·Granted Jan 28, 2014·1 cites·14 claims
- 3370US7935342B2Methods for treating obesity by administering a trkB antagonistRINAT NEUROSCIENCE CORP·Filed 2007·Granted May 3, 2011·2 cites·13 claims
- 3467US11008386B2Anti-NGF antibodies and methods using sameRINAT NEUROSCIENCE CORP·Filed 2017·Granted May 18, 2021·0 cites·4 claims
- 3567US2020157201A1Methods for treating osteoarthristis pain by administering a nerve growth factor antagonist and compositions containing the sameRINAT NEUROSCIENCE CORP·Filed 2019·Application pending·0 cites
- 3665US2021162058A1Engineered polypeptide conjugates using transglutaminaseRINAT NEUROSCIENCE CORP·Filed 2020·Application pending·0 cites
- 3764US11091544B2Antibodies specific for Trop-2 and their usesRINAT NEUROSCIENCE CORP·Filed 2018·Granted Aug 17, 2021·0 cites·8 claims
- 3861US9346885B2Method of treating type 1 diabetes with antagonist IL-7 receptor antibodiesRINAT NEUROSCIENCE CORP·Filed 2013·Granted May 24, 2016·0 cites·10 claims
- 3960US2018327503A1Antagonist anti-il-7 receptor antibodies and methodsRINAT NEUROSCIENCE CORP·Filed 2018·Application pending·0 cites
- 4059US2013236451A1Antibodies directed against amyloid-beta peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2013·Application pending·0 cites
- 4157US10059772B2Antagonist anti-IL-7 receptor antibodies and methodsRINAT NEUROSCIENCE CORP·Filed 2016·Granted Aug 28, 2018·0 cites·1 claims
- 4256US2009203610A1Methods of treating obesity or diabetes using nt-4/5RINAT NEUROSCIENCE CORP·Filed 2009·Application pending·0 cites
- 4355US2009291897A1Methods for treating unwanted weight loss or eating disorders by administering a trkb agonistRINAT NEUROSCIENCE CORP·Filed 2009·Application pending·0 cites
- 4454US2016096898A1Pc33718eRINAT NEUROSCIENCE CORP·Filed 2015·Application pending·0 cites
- 4554US2007014786A1Methods for treating taxol-induced gut disorderRINAT NEUROSCIENCE CORP·Filed 2004·Application pending·0 cites
- 4653US2016096884A1Antibodies directed against amyloid-beta peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2015·Application pending·0 cites
- 4750US2011038861A1Methods of Treating Alzheimer's Disease Using Antibodies Directed Against Amyloid Beta Peptide and Compositions ThereofRINAT NEUROSCIENCE CORP·Filed 2010·Application pending·0 cites
- 4848US2009022728A1Methods of treating ophthalmic diseasesRINAT NEUROSCIENCE CORP·Filed 2008·Application pending·0 cites
- 4947US2007275374A1Methods For Idendifying Drug Targets And Modulators Of Neurons and Compositions Comprising The SameRINAT NEUROSCIENCE CORP·Filed 2004·Application pending·0 cites
- 5044US9249224B2Human growth hormone receptor antagonist antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2012·Granted Feb 2, 2016·0 cites·12 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when RINAT NEUROSCIENCE CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →